Meyka AI API is live for developers.Start building.
Advertisement
Becton, Dickinson and Company

Becton, Dickinson and Company (BDX) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

BDXNYSE
HealthcareMedical - Instruments & Supplies
$151.16
$1.60(1.07%)
U.S. Market opens in 59h 15m
Advertisement

Becton, Dickinson and Company (BDX)

Meyka AI Score

Z

Key Financials

Market Cap54.8B
P/E Ratio37.42
EPS (TTM)$5.74
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$156.25
3 Months$137.73
1 Year Target$157.39

BDX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $157.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.42 and a market capitalization of 54.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.07%
5-Day Change
1.96%
1-Month Change
4.85%
3-Month Change
-11.05%
6-Month Change
-0.87%
Year-to-Date (YTD) Change
-0.92%
1-Year Change
12.42%
3-Year Change
-24.30%
5-Year Change
-17.73%
All-Time (Max) Change
553.81%

Contact Information

201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

70,000 Employees
IPO DateFeb 21, 1973
CountryUS
Actively Trading

Frequently Asked Questions